JavaScript is disabled in your browser. Please enable JavaScript to view this website.
AB263242

Human KLHDC3 knockout HEK-293T cell lysate

Be the first to review this product! 리뷰 제출

|

(0 출판물)

KLHDC3 KO cell lysate available now. KO validated. Free of charge wild type control included. Knockout achieved by using CRISPR/Cas9, 1 bp insertion in exon2.
1 이미지
Sanger Sequencing - Human KLHDC3 knockout HEK-293T cell lysate (AB263242)
  • Sanger seq

Unknown

Sanger Sequencing - Human KLHDC3 knockout HEK-293T cell lysate (AB263242)

Homozygous : 1 bp insertion in exon2

주요 정보

세포 유형

HEK-293T

Species or organism

Human

조직

Kidney

Knockout 검증

Sanger Sequencing

Mutation 정보

Knockout achieved by using CRISPR/Cas9, 1 bp insertion in exon2.

제품 세부 정보

Knockout cell lysate achieved by CRISPR/Cas9.

REACH authorisation
Abcam has not and does not intend to apply for the REACH Authorisation of customers' uses of products that contain European Authorisation list (Annex XIV) substances.
It is the responsibility of our customers to check the necessity of application of REACH Authorisation, and any other relevant authorisations, for their intended uses.

Lysate preparation: Our lysates are made using RIPA buffer to which we add a protease inhibitor cocktail and phosphatase inhibitor cocktail (ratio: 300:100:10). This means that the protein of interest is denatured. If you require a native form of the protein please use the live cell version. Please refer to our lysis protocol for further details on how our lysates are prepared.

User storage instructions: Lyophilizate may be stored at 4°C. After reconstitution, store at -20°C for short-term storage or -80°C for long-term storage.

This product is subject to limited use licenses from The Broad Institute, ERS Genomics Limited and Sigma-Aldrich Co. LLC, and is developed with patented technology. For full details of the licenses and patents please refer to our limited use license and patent pages.

제품 구성

{ "values": { "1Kit": { "sellingSize": "1 Kit", "publicAssetCode":"ab263242-1Kit", "assetComponentDetails": [ { "size":"1 x 100 µg", "name":"Human KLHDC3 knockout HEK293T cell lysate", "number":"AB263242-CMP01", "productcode":"" }, { "size":"1 x 100 µg", "name":"Human wild-type HEK293T cell lysate", "number":"AB263242-CMP02", "productcode":"" } ] } } }

특성 및 보관 정보

유전자명
KLHDC3
유전자 편집 종류
Knockout
유전자 편집 방식
CRISPR technology
Knockout 검증
Sanger Sequencing
배송 시 보관 조건
Ambient - Can Ship with Ice
적절한 단기 보관 조건
-20°C
적절한 장기 보관 조건
-20°C

추가 정보

This supplementary information is collated from multiple sources and compiled automatically.

KLHDC3 also known as Kelch Domain Containing 3 is a protein with a mass of approximately 30 kDa. It is characterized by the presence of a Kelch domain which enables protein-protein interactions. It is expressed in various tissues with notable presence in the brain and testes. This protein is part of the Kelch domain-containing family which often plays roles in scaffolding and organizing protein complexes within cells.
Biological function summary

KLHDC3 participates in cellular processes such as transcriptional regulation and cell cycle control. It is involved in forming protein complexes that modify transcriptional responses. These complexes interact with a variety of transcription factors impacting gene expression. KLHDC3 also regulates the stability and degradation of certain proteins by acting as an adapter for ubiquitination processes.

Pathways

KLHDC3 plays a role in critical pathways like the ubiquitin-proteasome system and the Wnt signaling pathway. It interacts with proteins involved in these pathways such as Beta-catenin influencing cellular growth and development. The ubiquitin-proteasome system is essential for protein turnover while Wnt signaling regulates gene transcription that affects embryogenesis and cell proliferation.

KLHDC3 has been linked to disorders like neurodegenerative diseases and certain cancers. Aberrant functioning of KLHDC3 or its related pathways can disrupt normal cellular processes leading to disease development. For example its interaction with Beta-catenin can influence pathways associated with tumor progression. Further research aims to understand how KLHDC3 modulations contribute to disease pathology and may guide therapeutic approaches.

품질 관리

STR analysis

CSF1PO, D13S317, D7S820, D5S818, TH01, D16S539, TPOX

Cell culture

Biosafety level

EU: 2 US: 2

Adherent/suspension

Adherent

Gender

Female

제품 프로토콜

Product promise

저희는 고품질 시약으로 고객님의 연구를 서포트하고자 최선을 다하고 있으며, 모든 단계에서 함께 하겠습니다. 만약 제품이 기대한 성능을 보이지 않을 경우에도 Product Promise로 보호받으실 수 있습니다.
자세한 내용은 이용 약관을 확인해 주세요.

Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.

For licensing inquiries, please contact partnerships@abcam.com